Replies to post #3600 on Kitov Pharmaceuticals Hldgs L Sponsored ADR (KTOV)

[ash111]

it's hard to predict, 3 scenarios imo: 1. an agreement to marketing kit-302 by another Pharma 2. by Dexcel http://www.dexcel.com/company-profile/ (they already have an agreement), 3. a Buy-out by Pfizer or another big Pharma. as i mentioned before,a pocket change money for Pfizer to acquire. imo.
Celebrex(Pfizer Drug) has major risks while KTOV has an improved Celebrex (Combo).folks might drop Celebrex overnight and switch to Kitov drug and not worry about side effects. with the improved celebrex Pfizer could easily pass $2.4B(2014 sales) even $3B sales IMO.

i'm still betting on a BO before market launch